PainQx
PainQx is an AI-powered medical device company developing the ALGOS System, an objective pain measurement technology for chronic pain assessment serving healthcare providers, hospitals, and research institutions.
- Company typePrivate
- Founded2015
- HeadquartersNew York, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
PainQx firmographics
Firmographics- Name
- PainQx
- Legal name
- PainQx, Inc.
- Website
- https://painqx.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- PainQx is an AI-powered medical device company developing the ALGOS System, an objective pain measurement technology for chronic pain assessment serving healthcare providers, hospitals, and research institutions.
- Ownership category
- akta.pro rank
PainQx industry classification
Industry- Product category
- Medical Device Software
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)
- akta.pro secondary industries
- SaMD – Digital Biomarkers & Algorithmic Endpoints (HLACANAF), DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms (HLACANAM), DTx/SaMD Deployment, Integration & Reimbursement Enablement (HLACANAO)
Keywords
Where PainQx is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Markets served
PainQx business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations
Revenue model
- Government Research Contracts: PainQx generates revenue through Small Business Innovation Research (SBIR) Phase II contract from the Defense Health Agency, valued at $1.5 million. This funding supports research, algorithm refinement, and FDA preparation activities.
Go-to-market motion1 record
PainQx product offering
Product offeringCore offering
PainQx develops the ALGOS System, an AI-enabled pain assessment technology designed to objectively measure and monitor chronic pain in humans. The system uses proprietary machine learning algorithms to analyze pain-related data and produce quantified pain assessments, moving beyond subjective patient self-reporting. The company is conducting multi-site research and pursuing FDA regulatory preparation for commercialization as a medical device.
Differentiator
Problem solved
Functional benefit
Products and services
- ALGOS System An AI-enabled pain assessment technology designed to objectively quantify and monitor chronic pain in humans. The system uses proprietary machine learning algorithms to analyze pain-related data and produce measurable pain assessments, replacing subjective patient self-reporting. It is intended for use by medical professionals, hospitals, clinics, and research institutions.
Companies that use PainQx
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles2 records
PainQx technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature1 record
PainQx partnerships and signals
Strategic signalScale indicators1 record
PainQx competitors and assessment
Company assessmentDirect peers
- PainChek: PainChek provides AI-powered pain assessment tools, primarily for patients who cannot self-report (e.g., dementia, non-verbal). It is directly comparable in using AI/ML to produce objective pain scores, though PainChek is more mature and commercially deployed in aged care.
- Medasense Biometrics: Medasense develops the PMD-200 (NOL index), an objective AI-based pain monitoring technology used during surgery and critical care. It is the closest direct competitor to PainQx's ALGOS, addressing the same fundamental unmet need of objective pain quantification.
Broad incumbents
- Masimo: Masimo is a leading patient monitoring and medical technology company with multiple AI/ML-enabled measurement parameters. While focused on pulse oximetry and broader monitoring, it has the R&D scale and clinical channel to enter or compete in objective pain measurement.
- SPR Therapeutics: SPR Therapeutics is a commercial-stage medical device company focused on peripheral nerve stimulation for chronic and acute pain. It is comparable as a pain-focused medical device company, though its approach is interventional rather than AI-based pain measurement.
- Abbott (Neuromodulation / Proclaim DRG): Abbott operates a major neuromodulation business (Proclaim DRG, Proclaim XR) targeting chronic pain. It is a broad incumbent in the pain device space with the capital, regulatory infrastructure, and clinical reach to either compete with or acquire AI pain measurement technologies.
- Boston Scientific: Boston Scientific has a sizable neuromodulation and pain management portfolio (including Vertiflex, WaveWriter, and other spinal cord stimulators). It is a broad incumbent in the chronic pain device market and a potential strategic acquirer of objective pain biomarkers.
Emerging players
- Hinge Health: Hinge Health is a digital MSK and chronic pain care platform combining exercise therapy, coaching, and (in some cases) AI-based motion tracking. It addresses chronic pain at scale, intersecting with PainQx's downstream objective measurement use case for treatment response.
- Sword Health: Sword Health is a digital MSK and pelvic health platform using AI to monitor patient movement and pain outcomes. It overlaps with PainQx in the chronic pain market and in using AI to quantify subjective clinical endpoints.
- AppliedVR: AppliedVR develops FDA-authorized virtual reality therapeutics for chronic pain, and the company uses pain outcome measurement as a core part of its value proposition. It is comparable as an emerging digital pain therapeutics player where pain measurement is mission-critical.
- Curelator (now part of StatLife): Curelator/StatLife develops data-driven platforms for tracking and predicting pain episodes (e.g., migraine) in individual patients. It is comparable to PainQx as an emerging player in AI/data-driven pain phenotyping, though focused on headache and patient-reported data.
Market position
Customer concentration
PainQx social profiles
Digital presencePainQx financial estimates
Financial estimateRevenue estimate
Valuation estimate
PainQx leadership team
Management profileNumber of profiles
Profiles3 records
PainQx funding detail
Funding detailFunding overview
Funding rounds5 records
Investors12 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PainQx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PainQx
What does PainQx do?
PainQx develops the ALGOS System, an AI-enabled pain assessment technology designed to objectively measure and monitor chronic pain in humans. The system uses proprietary machine learning algorithms to analyze pain-related data and produce quantified pain assessments, moving beyond subjective patient self-reporting. The company is conducting multi-site research and pursuing FDA regulatory preparation for commercialization as a medical device.
Is PainQx a public or private company?
PainQx is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was PainQx founded?
PainQx was founded in 2015. It employs 1 to 10 people.
Where is PainQx based?
PainQx is headquartered in New York, United States, in the North America region.
How does PainQx make money?
One revenue line is on record: government Research Contracts.
Who are PainQx's main competitors?
Direct peers on record are PainChek and Medasense Biometrics. Broad incumbents are Masimo, SPR Therapeutics, Abbott (Neuromodulation / Proclaim DRG) and Boston Scientific. Emerging players are Hinge Health, Sword Health, AppliedVR and Curelator (now part of StatLife).
Does PainQx have an API?
No public API is recorded for PainQx.
What industry is PainQx in?
PainQx's product category is Medical Device Software. Its primary akta.pro industry code is HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML), with a secondary code of HLACANAF, SaMD – Digital Biomarkers & Algorithmic Endpoints. Its NAICS code is 334510 and its SIC code is 3845.